CytomX Therapeutics Provides Business Update and Outlines 2023 Company Priorities
Go back to CytomX Therapeutics Provides Business Update and Outlines 2023 Company Priorities| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.36 +0.15 (4.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $24.68 | |||
| Open | $3.20 | 52 Week Low | $9.10 | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $0.00 | |||
| Volume | 2,381,223 | |||||
